• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

G06:GR

6.040 EUR 0.257 4.44%

As of 11:19:42 ET on 07/28/2014.

Snapshot for Genticel SA (G06)

Open: 5.802 Day's Range: 5.790 - 6.040 Volume: 0
Previous Close: 5.783 52wk Range: 5.298 - 7.079 1-Yr Rtn: -

Stock Chart for G06

No chart data available.
  • G06:GR 6.040
  • 1D
  • 1M
  • 1Y
5.783
Interactive G06 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for G06

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) -0.5200
Est. PEG Ratio -
Market Cap (M EUR) 92.32
Shares Outstanding (M) 15.29
30 Day Average Volume 22
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for G06

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for G06

Genticel SA researches and develops biopharmaceutical products. The Company offers therapeutic vaccines for the prevention and treatment of human papillomavirus. Genticel conducts business in France.

Benedikt TimmermanChairman-Mgmt Bd/CEO/FounderMartin KochChief Financial Officer
Marie Christine BisseryChief Scientific OfficerSophie OlivierChief Medical Officer
More Company Profile & Key Executives for G06

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil